These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3329022)

  • 41. Stimulation of vascular dopamine receptors: status and future strategies.
    Berkowitz BA; Ohlstein EH
    Clin Exp Hypertens A; 1987; 9(5-6):1037-44. PubMed ID: 3304727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative evaluation of the effect of digoxin, strophanthin, isolanid and corglycon on the indices of central hemodynamics, vascular tonus, circulating blood volume and myocardial contractility in acute heart failure].
    Tsyganiĭ AA; Kovalev NL; Kozlovskiĭ VI; Malinovskiĭ OP; Pen'kov GI
    Anesteziol Reanimatol; 1981; (3):44-8. PubMed ID: 7294441
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine, hypertension and obesity.
    Contreras F; Fouillioux C; Bolívar A; Simonovis N; Hernández-Hernández R; Armas-Hernandez MJ; Velasco M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S13-7. PubMed ID: 11986886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of dobutamine on the cardiovascular system in subjects without circulatory failure].
    Dosiak J; Giec L; Drzewiecki J; Szulc A; Wnuk-Wojnar A; Jaklik A; Szcześniak S
    Kardiol Pol; 1982; 25(1):57-62. PubMed ID: 7098263
    [No Abstract]   [Full Text] [Related]  

  • 46. Dopamine receptors and the cardiovascular system.
    Clark BJ
    Postgrad Med J; 1981; 57 Suppl 1():45-54. PubMed ID: 6117848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heart disease in the elderly.
    Assey ME
    Heart Dis Stroke; 1993; 2(4):330-4. PubMed ID: 7908843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.
    Forte P; Martin G; Luchsinger A; Hernandez O; Romero E; Velasco M
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):404-6. PubMed ID: 8225687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The therapeutic potential of dopamine modulators on the cardiovascular and renal systems.
    Doggrell SA
    Expert Opin Investig Drugs; 2002 May; 11(5):631-44. PubMed ID: 11996645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine for treatment of shock.
    Med Lett Drugs Ther; 1975 Feb; 17(4):13-4. PubMed ID: 1128445
    [No Abstract]   [Full Text] [Related]  

  • 51. Presynaptic dopamine receptor stimulation and the antihypertensive action of pergolide in experimental neurogenic hypertension.
    Barrett RJ; Lokhandwala MF
    Proc West Pharmacol Soc; 1982; 25():39-42. PubMed ID: 7122527
    [No Abstract]   [Full Text] [Related]  

  • 52. The peripheral dopaminergic system. Basic and clinical advances.
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):1S-2S. PubMed ID: 1974437
    [No Abstract]   [Full Text] [Related]  

  • 53. The effects of some gastrointestinal hormones and metoclopramide on cardiovascular dopamine receptors [proceedings].
    Blower PR; Flack JD; Day MD
    Br J Pharmacol; 1977 Sep; 61(1):124P-125P. PubMed ID: 912177
    [No Abstract]   [Full Text] [Related]  

  • 54. Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow.
    Cavero I; Lefèvre-Borg F; Gomeni R
    J Pharmacol Exp Ther; 1981 Nov; 219(2):510-9. PubMed ID: 6116802
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
    Marchetti G; Merlo L
    Arzneimittelforschung; 1986 Feb; 36(2A):331-3. PubMed ID: 3707644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of carbon dioxide baths on cardiovascular function in ischemic heart disease in combination with hypertension].
    Nurkeeva SS
    Vopr Kurortol Fizioter Lech Fiz Kult; 1982; (5):60. PubMed ID: 6817515
    [No Abstract]   [Full Text] [Related]  

  • 57. Dopamine receptor stimulants in hypertension.
    Clark BJ
    Acta Med Scand Suppl; 1977; 606():95-100. PubMed ID: 268936
    [No Abstract]   [Full Text] [Related]  

  • 58. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in the management of chronic heart failure.
    Chatterjee K
    Prim Care; 1985 Mar; 12(1):117-42. PubMed ID: 3846305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral dopamine receptors in cardiovascular therapy. The legacy of Leon Goldberg (1927-1989).
    Kohli JD; McNay JL; Rajfer SI; Murphy MB
    Hypertension; 1991 May; 17(5):700-6. PubMed ID: 2022412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.